Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

Comparative statistics by cancer registry

(Harare, Zimbabwe, 1993-1997 cases* followed-up until 1999, all races together)

Click on cancer site (ICD-10 code) for comparison

Site	ICD-10	No. of cases included	Complete FU		Incomplete FU: loss to FU						% with Complete FU at 5 years	Median FU (in months)
			Alive/dead	At end of FU	No.	%	% lost to FU: years from diagnosis
			No.	%	No.	%	<1	1-3	3-5	>5
C15	Oesophagus	131	131	100.0	0	0.0	0.0	0.0	0.0	0.0	100.0	2.3
C16	Stomach	129	127	98.4	2	1.6	1.6	0.0	0.0	0.0	98.4	4.8
C18	Colon	57	57	100.0	0	0.0	0.0	0.0	0.0	0.0	100.0	14.6
C19-20	Rectum	67	65	97.0	2	3.0	1.5	1.5	0.0	0.0	97.0	16.1
C22	Liver	132	131	99.2	1	0.8	0.8	0.0	0.0	0.0	99.2	1.0
C32	Larynx	73	69	94.5	4	5.5	5.5	0.0	0.0	0.0	94.5	14.1
C33-34	Lung	116	116	100.0	0	0.0	0.0	0.0	0.0	0.0	100.0	2.0
C43	Melanoma skin	101	100	99.0	1	1.0	1.0	0.0	0.0	0.0	99.0	54.2
C46	Kaposi sarcoma	151	151	100.0	0	0.0	0.0	0.0	0.0	0.0	100.0	3.4
C50	Breast	258	250	96.9	8	3.1	2.7	0.4	0.0	0.0	96.9	39.3
C53	Cervix	264	260	98.5	4	1.5	1.1	0.4	0.0	0.0	98.5	26.2
C56	Ovary	63	63	100.0	0	0.0	0.0	0.0	0.0	0.0	100.0	18.7
C61	Prostate	64	61	95.3	3	4.7	4.7	0.0	0.0	0.0	95.3	16.6
C67	Urinary bladder	130	127	97.7	3	2.3	1.5	0.8	0.0	0.0	97.7	11.8
C69	Eye	116	114	98.3	2	1.7	0.9	0.9	0.0	0.0	98.3	42.1
C81	Hodgkin lymphoma	39	39	100.0	0	0.0	0.0	0.0	0.0	0.0	100.0	30.6
C82-85+C96	Non-Hodgkin lymphoma	99	97	98.0	2	2.0	2.0	0.0	0.0	0.0	98.0	7.8

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Harare, Zimbabwe, 1993-1997 cases* followed-up until 1999, all races together)
- Table2a:	Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Harare, Zimbabwe, 1993-1997 cases* followed-up until 1999, all races together)
- Table4:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Harare, Zimbabwe, all races, 1993-1997 cases* followed-up until 1999)

Registry chapter: